HRP931504B1 - Novel peptides, their production and use - Google Patents

Novel peptides, their production and use

Info

Publication number
HRP931504B1
HRP931504B1 HR931504A HRP931504A HRP931504B1 HR P931504 B1 HRP931504 B1 HR P931504B1 HR 931504 A HR931504 A HR 931504A HR P931504 A HRP931504 A HR P931504A HR P931504 B1 HRP931504 B1 HR P931504B1
Authority
HR
Croatia
Prior art keywords
production
novel peptides
novel
peptides
chdcheco
Prior art date
Application number
HR931504A
Other languages
English (en)
Inventor
Andreas Haupt
Bernd Janssen
Kurt Ritter
Dagmar Klinge
Gerhard Keilhauer
Cynthia Romerdahl
Teresa Barlozzari
Xiao-Dong Quian
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP931504A2 publication Critical patent/HRP931504A2/xx
Publication of HRP931504B1 publication Critical patent/HRP931504B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Window Of Vehicle (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR931504A 1992-12-16 1993-12-16 Novel peptides, their production and use HRP931504B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16

Publications (2)

Publication Number Publication Date
HRP931504A2 HRP931504A2 (en) 1997-02-28
HRP931504B1 true HRP931504B1 (en) 2001-04-30

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
HR931504A HRP931504B1 (en) 1992-12-16 1993-12-16 Novel peptides, their production and use

Country Status (24)

Country Link
US (1) US5502032A (zh)
EP (1) EP0674652B1 (zh)
JP (1) JPH08504415A (zh)
CN (1) CN1057095C (zh)
AT (1) ATE196296T1 (zh)
AU (1) AU679479B2 (zh)
BR (1) BR1100019A (zh)
CA (1) CA2151953A1 (zh)
CZ (1) CZ286752B6 (zh)
DE (1) DE69329425T2 (zh)
ES (1) ES2151921T3 (zh)
FI (1) FI952961A0 (zh)
HR (1) HRP931504B1 (zh)
HU (1) HUT72067A (zh)
IL (1) IL107987A (zh)
NO (1) NO952366L (zh)
NZ (1) NZ258882A (zh)
PL (1) PL178766B1 (zh)
RU (1) RU2132334C1 (zh)
SG (1) SG67935A1 (zh)
SI (1) SI9300661A (zh)
TW (1) TW400335B (zh)
WO (1) WO1994013695A1 (zh)
ZA (1) ZA939389B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
AU760174B2 (en) 1999-02-09 2003-05-08 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
EP1358178A2 (en) * 2001-01-30 2003-11-05 Bristol-Myers Squibb Company Sulfonamide lactam inhibitors of factor xa
JP2005509616A (ja) * 2001-10-16 2005-04-14 センジェント・セラピューティクス・インク チロシンホスファターゼに対する有機硫黄阻害剤
US7087604B2 (en) 2002-03-08 2006-08-08 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
EP1636220A1 (en) * 2003-05-12 2006-03-22 Pfizer Products Inc. Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
WO2006009876A2 (en) * 2004-06-17 2006-01-26 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
JP2008505916A (ja) * 2004-07-09 2008-02-28 メタバシス・セラピューティクス・インコーポレイテッド チロシンホスファターゼの酸素／窒素複素環阻害剤
EP1841749A1 (en) 2004-09-02 2007-10-10 Metabasis Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
EP3498289A1 (en) 2005-07-07 2019-06-19 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
CN106110332B (zh) 2011-06-10 2018-11-30 梅尔莎纳医疗公司 蛋白质-聚合物-药物共轭物
WO2014093379A1 (en) 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
EP3590922A1 (en) 2013-03-15 2020-01-08 Zymeworks Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
ES2916722T3 (es) 2013-12-27 2022-07-05 Zymeworks Inc Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
CN106459162A (zh) 2013-12-27 2017-02-22 酵活有限公司 Var2csa‑药物偶联物
CN113416229A (zh) 2014-09-17 2021-09-21 酵活有限公司 细胞毒性和抗有丝分裂化合物、及其使用方法
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
AU2022338463A1 (en) 2021-09-03 2024-03-21 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
EP0357332A3 (en) * 1988-08-24 1991-07-31 Merck & Co. Inc. Renin inhibitors useful for the treatment of aids by inhibition of hiv protease
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat

Also Published As

Publication number Publication date
CA2151953A1 (en) 1994-06-23
WO1994013695A1 (en) 1994-06-23
HU9501754D0 (en) 1995-08-28
CN1095724A (zh) 1994-11-30
IL107987A (en) 1999-10-28
ATE196296T1 (de) 2000-09-15
DE69329425D1 (de) 2000-10-19
SI9300661A (en) 1994-06-30
CN1057095C (zh) 2000-10-04
PL178766B1 (pl) 2000-06-30
SG67935A1 (en) 1999-10-19
IL107987A0 (en) 1994-04-12
CZ157595A3 (en) 1996-01-17
ES2151921T3 (es) 2001-01-16
EP0674652A1 (en) 1995-10-04
RU2132334C1 (ru) 1999-06-27
AU679479B2 (en) 1997-07-03
DE69329425T2 (de) 2001-01-18
CZ286752B6 (en) 2000-06-14
BR1100019A (pt) 2000-07-25
EP0674652B1 (en) 2000-09-13
FI952961A (fi) 1995-06-15
NO952366D0 (no) 1995-06-15
US5502032A (en) 1996-03-26
JPH08504415A (ja) 1996-05-14
HUT72067A (en) 1996-03-28
HRP931504A2 (en) 1997-02-28
NZ258882A (en) 1997-06-24
NO952366L (no) 1995-06-15
TW400335B (en) 2000-08-01
ZA939389B (en) 1995-06-15
PL309353A1 (en) 1995-10-02
FI952961A0 (fi) 1995-06-15
AU5695994A (en) 1994-07-04
RU95115135A (ru) 1997-06-10

Similar Documents

Publication Publication Date Title
HRP931504A2 (en) Novel peptides, their production and use
MY124487A (en) Dolastatin derivatives, their preparation and use
HUT71398A (en) Derivatives of dolastatin
CA2111083A1 (en) Novel peptides, their preparation and use
ZA919752B (en) Fluorine compounds
TW224461B (zh)
MY114327A (en) Novel peptides, the preparation and use thereof
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
ES8606298A1 (es) 1.4-dihidropirazinas

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20011216

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20021217